在急性缺血性中风中C反应性蛋白表达血栓:对病因学的影响
Wenyi Liu1, Cansu Sahin1,2, Nazan Güner Sak1,2
1Department of Physiology, University of Galway, Galway, Ireland.
European stroke journal
|February 6, 2025
概括
在中风血块中C反应蛋白 (CRP) 表明炎症. 心血管栓塞中风显示CRP水平较高,这表明与炎症和纤维素丰富的血块有联系,可能改善对血栓炎症的理解.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 生物标志物研究 生物标志物研究
背景情况:
- C-反应蛋白 (CRP) 是一个关键的炎症标志物,与脑血管事件风险有关.
- 了解CRP在不同急性缺血性中风 (AIS) 亚型中的作用对于病因学确定至关重要.
研究的目的:
- 为了研究急性缺血性中风 (AIS) 血块中的C反应蛋白 (CRP) 表达.
- 为了确定CRP水平是否在大动脉动脉样硬化 (LAA),心血管栓塞 (CE) 和密码性 (Crypt) 卒中亚型中存在差异.
- 探索AIS凝块中的CRP,纤维素和白细胞 (WBC) 之间的关联.
主要方法:
- 来自Clotbase国际注册表的AIS血块样本 (n=50个亚型:LAA,CE,Crypt) 的分析.
- 免疫组织化学和免疫光学评估CRP表达和同局部化与凝块成分.
- 马修斯红蓝色染色用于凝块成分分析和跨病因学临床参数的比较.
主要成果:
- 35%的AIS血块表现出大量的CRP表达 (>1%),而65%的表达最小 (<=1%).
- 与LAA (30%) 和Crypt (26%) 亚型 (p=0.048) 相比,心血管栓塞 (CE) 血栓的实质性CRP水平 (48%) 显著更高.
- 有大量CRP的血块含有纤维素含量增加 (28.9%) 与低CRP血块 (20.6%; p=0.005),CRP与纤维素和白细胞共局部.
结论:
- 在CE中风凝块中CRP升高表明这种亚型中具有更强烈的炎症成分.
- 实质性CRP和凝块中纤维素增加之间的关联表明,炎症在富含纤维素的凝块形成中起着作用.
- 对血栓中CRP,纤维素和白血细胞相互作用的进一步研究可能会阐明血栓炎症过程.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
43
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
43
Clot Retraction and Fibrinolysis
3.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.6K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
86
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
86
Anticoagulant Drugs: Low-Molecular-Weight Heparins
601
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
601
Extrinsic and Intrinsic Pathways of Hemostasis
5.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.0K
Formation of the Platelet Plug
3.9K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.9K


